Mesoblast and Cephalon in Largest Regenerative Medicine Deal to Date
By Heather Cartwright
Pharma Deals Review: Vol 2010 Issue 10 (Table of Contents)
Published: 30 Dec-2010
DOI: 10.3833/pdr.v2010.i10.1414 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Mesoblast, the Australian adult stem cell developer, has partnered with Cephalon in what is the largest regenerative medicine deal to date...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS